Lemaitre Vascular (LMAT) Inventory Average (2011 - 2026)
Lemaitre Vascular's (LMAT) quarterly Inventory Average came in at $70.7 million in Q2 2026, up 5.24% year-over-year from $67.1 million in Q2 2025, and little changed quarter-over-quarter from $70.6 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Inventory Average (2011 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Inventory Average for 16 consecutive years, with $70.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Inventory Average rose 5.24% year-over-year to $70.7 million in Q2 2026; TTM through Jun 2026 was $70.7 million, a 5.24% increase from a year earlier, with the FY2025 full-year figure at $67.7 million, up 10.03% from the prior year.
- Inventory Average was $70.7 million for Q2 2026 at Lemaitre Vascular, roughly flat from $70.6 million in the prior quarter.
- Over five years, Inventory Average peaked at $70.7 million in Q2 2026 and troughed at $46.4 million in Q1 2022.
- A 5-year average of $59.6 million and a median of $60.7 million in 2024 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average grew 2.86% in 2022 and increased 16.98% in 2024, its largest moves.
- Over 5 years, Inventory Average stood at $49.0 million in 2022, then increased by 16.62% to $57.1 million in 2023, then advanced by 13.72% to $65.0 million in 2024, then grew by 8.67% to $70.6 million in 2025, then climbed by 0.08% to $70.7 million in 2026.
- The last three Inventory Average figures came in at $70.7 million (Q2 2026), $70.6 million (Q1 2026), and $70.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 7.15 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.99 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 6.08 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 5.47 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 3.18 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1.13 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 2.47 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 710.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 671.95 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 70.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 70.66 Mn |
| Mar 31, 2026 | 70.62 Mn |
| Dec 31, 2025 | 70.61 Mn |
| Sep 30, 2025 | 69.59 Mn |
| Jun 30, 2025 | 67.15 Mn |
| Mar 31, 2025 | 65.42 Mn |
| Dec 31, 2024 | 64.97 Mn |
| Sep 30, 2024 | 64.35 Mn |
| Jun 30, 2024 | 62.12 Mn |
| Mar 31, 2024 | 59.33 Mn |
| Dec 31, 2023 | 57.13 Mn |
| Sep 30, 2023 | 55.01 Mn |
| Jun 30, 2023 | 53.81 Mn |
| Mar 31, 2023 | 52.03 Mn |
| Dec 31, 2022 | 48.99 Mn |
| Sep 30, 2022 | 47.45 Mn |
| Jun 30, 2022 | 46.93 Mn |
| Mar 31, 2022 | 46.38 Mn |
| Dec 31, 2021 | 45.22 Mn |
| Sep 30, 2021 | 44.54 Mn |